Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA nod to JnJ Tremfya for Crohns disease

JnJ sues researchers who linked talc to cancer

Ruchika Sharma14 July 2023 3:00 PM IST

New Jersey: Johnson & Johnson has sued four doctors who published studies citing links between talc-based personal care products and cancer,...

Gland Pharma Gets USFDA Approval for Olopatadine Ophthalmic Solution

Gland Pharma gets one 483 Observation from USFDA for Dundigal facility

Ruchika Sharma14 July 2023 1:29 PM IST

Hyderabad: Gland Pharma today announced that the United States Food and Drug Administration (USFDA) has issued one 483 Observation...

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

USFDA issues EIR for Granules India Gagillapur facility

Ruchika Sharma14 July 2023 12:15 PM IST

Telangana: Indian pharmaceutical company, Graules India Limited, has announced that the US Food and Drug Administration (US FDA) has issued...

Granules India inaugurates two advanced Centres of Excellence at IIT Hyderabad

Granules India arm bags USFDA nod for Acetaminophen and Ibuprofen Tablets

Ruchika Sharma14 July 2023 11:09 AM IST

Acetaminophen and Ibuprofen Tablets are used for temporary relief for minor aches and pains due to: headache, toothache, backache, menstrual cramps,...

Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe

Global spending on COVID 19 expected to touch USD 500 billion by 2027: Dr Reddy's Labs

Ruchika Sharma13 July 2023 3:15 PM IST

New Delhi: Though the World Health Organisation lifted the emergency tag on COVID-19, global spending on the disease, including research to improve...

Serum Institute Gets NPPA Nod to Discontinue Two Pack Sizes of Tetanus Toxoid Vaccine

WHO prequalifies SII Multivalent meningococcal meningitis vaccine

Ruchika Sharma13 July 2023 2:10 PM IST

MenFive is approved by WHO for use in individuals 1 through 85 years of age and will initially be available for use in reactive vaccine campaigns for...

Lupin secures SBTi validation for emission reduction targets

USFDA issues two observations for Lupin Nagpur facility

Ruchika Sharma13 July 2023 1:04 PM IST

Mumbai: Lupin has announced the United States Food and Drug Administration (USFDA) has concluded the inspection at the...

Dr Reddys Gets CDSCO Panel Approval To Begin Phase III Trial of Tapinarof Cream

Dr Reddy's Labs proposed rituximab biosimilar application accepted for review by USFDA, EMA and MHRA

Ruchika Sharma13 July 2023 12:02 PM IST

DRL_RI is being developed as a biosimilar of Rituxan / MabThera (rituximab), a cluster of differentiation 20 (CD20) directed cytolytic antibody.

Aurobindo Pharma arm bags USFDA nod for Sevelamer Hydrochloride Tablets

Ruchika Sharma13 July 2023 11:03 AM IST

Sevelamer Hydrochloride Tablets 400 mg and 800 mg is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on...

Jurors urged to impose heavy punitive damages in JnJ talc trial

Ruchika Sharma12 July 2023 4:30 PM IST

Lawyers for a California man who says he developed a rare cancer from exposure to asbestos in Johnson & Johnson's talc-based baby powder on...

Takeda voluntary withdraws US Biologics License Application for Dengue vaccine

Ruchika Sharma12 July 2023 3:30 PM IST

Takeda's tetravalent dengue vaccine candidate (TAK-003) is based on a live-attenuated dengue serotype 2 virus, which provides the genetic "backbone"...

JnJ electrosurgical tools recall classified as most serious by USFDA

Ruchika Sharma12 July 2023 2:30 PM IST

J&J MedTech said during the investigation into burn injuries related to use of the devices, it was determined that in some instances the products were...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok